GMAB
Genmab AS
NASDAQ: GMAB · HEALTHCARE · BIOTECHNOLOGY
$26.11
-2.54% today
Updated 2026-04-29
Market cap
$16.45B
P/E ratio
17.40
P/S ratio
4.42x
EPS (TTM)
$1.54
Dividend yield
—
52W range
$19 – $35
Volume
1.7M
Genmab AS (GMAB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.37B | $1.80B | $3.96B | $3.26B | $2.22B | $2.48B | $1.56B | $1.69B | $1.73B | $2.87B | $3.90B | $5.24B | $6.60B | $8.46B | $15.14B | $21.14B | $24.63B | $30.12B | $35.29B | $45.81B |
| Cash & equivalents | $381.35M | $429.07M | $131.75M | $70.01M | $460.74M | $100.95M | $65.20M | $66.99M | $168.13M | $359.09M | $873.99M | $307.02M | $1.35B | $532.91M | $3.55B | $7.26B | $8.96B | $9.89B | $14.87B | $9.86B |
| Current assets | $1.32B | $1.77B | $3.92B | $1.97B | $2.16B | $2.42B | $1.52B | $1.65B | $1.69B | $2.77B | $3.67B | $4.90B | $6.06B | $7.43B | $13.96B | $18.79B | $22.74B | $28.22B | $33.14B | $27.85B |
| Total liabilities | $251.66M | $197.05M | $1.08B | $1.07B | $924.34M | $1.40B | $1.08B | $1.31B | $1.07B | $833.74M | $415.83M | $411.54M | $330.75M | $446.64M | $1.10B | $2.02B | $2.43B | $2.84B | $3.68B | $9.11B |
| Current liabilities | $237.18M | $185.80M | $1.07B | $1.06B | $894.34M | $1.32B | $976.73M | $1.18B | $907.50M | $655.97M | $414.39M | $411.54M | $327.12M | $443.35M | $938.00M | $1.25B | $1.57B | $1.82B | $2.48B | $5.31B |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| Shareholder equity | $1.12B | $1.61B | $2.88B | $2.19B | $1.30B | $1.08B | $486.42M | $383.19M | $659.52M | $2.03B | $3.49B | $4.83B | $6.27B | $8.01B | $14.05B | $19.12B | $22.20B | $27.28B | $31.61B | $36.70B |
| Retained earnings | $-1.85B | $-2.21B | $-2.51B | $-3.32B | $-4.17B | $-4.43B | $-5.01B | $-5.48B | $-5.36B | $-5.03B | $-4.23B | $-3.11B | $-1.85B | $-197.46M | $2.13B | $7.11B | $10.02B | $14.81B | $19.02B | $23.55B |
| Accounts receivable | — | — | — | $1.69B | — | — | $71.21M | $136.69M | $136.00M | $105.84M | $174.66M | $975.67M | $579.00M | $1.33B | $2.99B | $2.46B | $3.37B | $5.71B | $4.95B | $6.69B |
| Inventory | — | — | — | $34.59M | — | — | — | $1.00 | — | — | $0.00 | $0.00 | $1.00 | $0.00 | $-10.40B | $-249.00M | $-31.00M | $-143.00M | $57.00M | $62.00M |
| Goodwill | — | — | — | $313.83M | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | $0.00 | $2.54B |